Quick Takeaways
- Voss Capital, LP filed SCHEDULE 13G for ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (ACTU).
- Disclosed ownership: 5.3%.
- Date of event: 15 Dec 2025.
Quoteable Key Fact
"Voss Capital, LP disclosed 5.3% ownership in ACTUATE THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (ACTU) on 15 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 5.3% | 1,227,756 | 1,200,000 | 27,756 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member | |
| Cocke Travis W. | 5.3% | 1,227,756 | 1,200,000 | 27,756 | /s/ Travis W. Cocke | Travis W. Cocke | |
| Voss Advisors GP, LLC | 1.1% | 250,000 | 250,000 | 0 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member | |
| Voss Value Master Fund, LP | 0.9% | 200,000 | 200,000 | 0 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner | |
| Voss Value-Oriented Special Situations Fund, LP | 0.2% | 50,000 | 50,000 | 0 | /s/ Travis W. Cocke | Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner |